| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:aileron_therapeutics [2023/05/11 22:12]
liam | pharmaceutical_companies:aileron_therapeutics [2024/10/28 18:44] (current)
liam [External links] |
|---|
| |
| **Aileron Therapeutics** is an American biopharmaceutical company based in [[united_states:massachusetts:Cambridge]], [[united_states:Massachusetts]]. | **Aileron Therapeutics** is an American biopharmaceutical company based in [[united_states:massachusetts:Cambridge]], [[united_states:Massachusetts]]. |
| | |
| | ===== Organization ===== |
| | |
| | ==== Personnel ==== |
| | |
| | ^ Aileron Therapeutics - Team ^^^ |
| | ^ Name ^ Position ^ Notes ^ |
| | | [[:Loren Walensky]] | Scientific Advisory Board member and consultant((Mourtada, R., Herce, H. D., Yin, D. J., Moroco, J. A., Wales, T. E., Engen, J. R., & Walensky, L. D. (2019). //Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice.// Nature Biotechnology, 37(10), 1186–1197. https://doi.org/10.1038/s41587-019-0222-z)) | Married to [[:Rochelle Walensky]]; employed at [[:Dana-Farber Cancer Institute]]; Scientific Co-founder of [[Lytica Therapeutics]] | |
| | |
| | ==== Investors ==== |
| | |
| | Investors in Aileron Therapeutics include:((//Aileron Therapeutics - Funding, Financials, Valuation & Investors.// Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/organization/aileron-therapeutics/company_financials)) ((//Series A - Aileron Therapeutics - 2006-12-01 - Crunchbase Funding Round Profile.// Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-a--f1823f7a)) ((//Series D - Aileron Therapeutics - 2009-06-11 - Crunchbase Funding Round Profile.// Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-d--7c3c2e71)) ((//Series E - Aileron Therapeutics - 2014-10-29 - Crunchbase Funding Round Profile.// Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-e--740ce9be)) |
| | |
| | * [[:Acorn Bioventures]] |
| | * [[:Aju IB Investment]] |
| | * [[:Apple Tree Partners]] |
| | * [[:BVF Partners]] |
| | * [[:CB Health Ventures]] |
| | * [[Eli Lilly]] |
| | * [[:Excel Venture Management]] |
| | * [[:Grand Oaks Capital]] |
| | * [[:Lincoln Park Capital Fund]] |
| | * [[:Maven Investment Partners]] |
| | * [[:Novartis Venture Fund]] (NVF) |
| | * [[Roche]] |
| | * [[:Satter Investment Management]] |
| | * [[:SR One]] |
| |
| ===== External links ===== | ===== External links ===== |
| * [[https://www.crunchbase.com/organization/aileron-therapeutics|Crunchbase]] | * [[https://www.crunchbase.com/organization/aileron-therapeutics|Crunchbase]] |
| * [[https://aileronrx.com/|Website]] | * [[https://aileronrx.com/|Website]] |
| | * [[https://wiki.whiteroseintelligence.com/en/Aileron-Therapeutics|White Rose Wiki]] |
